Jinyu Bio-technology (SHA:600201) obtained the approval of China's agriculture and rural affairs ministry to manufacture trivalent and bivalent foot-and-mouth disease vaccines.
The two certificates are valid until July 2028, according to a Wednesday filing with the Shanghai bourse.
Shares of the biotechnology company closed 2% lower Wednesday.